A hingeless Fc fusion system for site-specific cleavage by IdeS

References

• Chamow SM, Ashkenazi A. Immunoadhesins: Principles and applications. Trends Biotechnol 1996; 14:52-60; PMID:8746117; http://dx.doi.org/10.1016/0167-7799(96)80921-8
   PubMed Web of Science ®Google Scholar
• Brown SJ, Becherer KA, Blumeyer K, Kautzer C, Axelrod F, Le H, McConnell SJ, Whalley A, Spinella DG. Expression and ligand binding assays of soluble cytokine receptor-immunoglobulin fusion proteins. Protein Expr Purif 1998; 14:120-4; PMID:9758759; http://dx.doi.org/10.1006/prep.1998.0940
   PubMed Web of Science ®Google Scholar
• Czajkowsky DM, Hu J, Shao Z, Pleass RJ. Fc-fusion proteins: New developments and future perspectives. EMBO Mol Med 2012; 4:1015-28; PMID:22837174; http://dx.doi.org/10.1002/emmm.201201379
   PubMed Web of Science ®Google Scholar
• Huang C. Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology. Curr Opin Biotechnol 2009; 20:692-9; PMID:19889530; http://dx.doi.org/10.1016/j.copbio.2009.10.010
   PubMed Web of Science ®Google Scholar
• Beck A, Reichert JM. Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies. MAbs 2011; 3:415-6; PMID:21785279; http://dx.doi.org/10.4161/mabs.3.5.17334
   PubMed Web of Science ®Google Scholar
• Chamow SM, Peers DH, Byrn RA, Mulkerrin MG, Harris RJ, Wang WC, Bjorkman PJ, Capon DJ, Ashkenazi A. Enzymatic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragments. Biochemistry 1990; 29:9885-91; PMID:2125484; http://dx.doi.org/10.1021/bi00494a019
   PubMed Web of Science ®Google Scholar
• Beck JT, Marsters SA, Harris RJ, Carter P, Ashkenazi A, Chamow SM. Generation of soluble interleukin-1 receptor from an immunoadhesin by specific cleavage. Mol Immunol 1994; 31:1335-44; PMID:7997245; http://dx.doi.org/10.1016/0161-5890(94)90052-3
   PubMed Web of Science ®Google Scholar
• Culouscou JM, Carlton GW, Aruffo A. HER4 receptor activation and phosphorylation of SHC proteins by recombinant heregulin-Fc fusion proteins. J Biol Chem 1995; 270:12857-63; PMID:7759543; http://dx.doi.org/10.1074/jbc.270.21.12857
   PubMed Web of Science ®Google Scholar
• Haspel J, Blanco C, Jacob J, Grumet M. System for cleavable Fc fusion proteins using tobacco etch virus (TEV) protease. BioTechniques 2001; 30:60-6; PMID:11196321
   PubMed Web of Science ®Google Scholar
• Vincents B, von Pawel-Rammingen U, Bjorck L, Abrahamson M. Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding. Biochemistry 2004; 43:15540-9; PMID:15581366; http://dx.doi.org/10.1021/bi048284d
   PubMed Web of Science ®Google Scholar
• von Pawel-Rammingen U, Johansson BP, Bjorck L. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J 2002; 21:1607-15; PMID:11927545; http://dx.doi.org/10.1093/emboj/21.7.1607
   PubMed Web of Science ®Google Scholar
• Lynaugh H, Li H, Gong B. Rapid Fc glycosylation analysis of Fc fusions with IdeS and liquid chromatography mass spectrometry. MAbs 2013; 5:641-5; PMID:23839239; http://dx.doi.org/10.4161/mabs.25302
   PubMed Web of Science ®Google Scholar
• Strand J, Huang CT, Xu J. Characterization of Fc-fusion protein aggregates derived from extracellular domain disulfide bond rearrangements. J Pharm Sci 2013; 102:441-53; PMID:23242781; http://dx.doi.org/10.1002/jps.23421
   PubMed Web of Science ®Google Scholar
• An Y, Zhang Y, Mueller HM, Shameem M, Chen X. A new tool for monoclonal antibody analysis: Application of IdeS proteolysis in IgG domain-specific characterization. MAbs 2014; 6:879-93; PMID:24927271; http://dx.doi.org/10.4161/mabs.28762
   PubMed Web of Science ®Google Scholar
• Mine S, Koshiba T, Honjo E, Okamoto T, Tamada T, Maeda Y, Matsukura Y, Horie A, Ishibashi M, Sato M, et al. Thermodynamic analysis of the activation mechanism of the GCSF receptor induced by ligand binding. Biochemistry 2004; 43:2458-64; PMID:14992583; http://dx.doi.org/10.1021/bi0356855
   PubMed Web of Science ®Google Scholar
• Schechter I, Berger A. On the size of the active site in proteases. I. papain. Biochem Biophys Res Commun 1967; 27:157-62; PMID:6035483; http://dx.doi.org/10.1016/S0006-291X(67)80055-X
   PubMed Web of Science ®Google Scholar
• Wenig K, Chatwell L, von Pawel-Rammingen U, Bjorck L, Huber R, Sondermann P. Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG. Proc Natl Acad Sci U S A 2004; 101:17371-6; PMID:15574492; http://dx.doi.org/10.1073/pnas.0407965101
   PubMed Web of Science ®Google Scholar
• Gong R, Vu BK, Feng Y, Prieto DA, Dyba MA, Walsh JD, Prabakaran P, Veenstra TD, Tarasov SG, Ishima R, et al. Engineered human antibody constant domains with increased stability. J Biol Chem 2009; 284:14203-10; PMID:19307178; http://dx.doi.org/10.1074/jbc.M900769200
   PubMed Web of Science ®Google Scholar
• Chevreux G, Tilly N, Bihoreau N. Fast analysis of recombinant monoclonal antibodies using IdeS proteolytic digestion and electrospray mass spectrometry. Anal Biochem 2011; 415:212-4; PMID:21596014; http://dx.doi.org/10.1016/j.ab.2011.04.030
   PubMed Web of Science ®Google Scholar
• Caaveiro JM, Kiyoshi M, Tsumoto K. Structural analysis of Fc/FcgammaR complexes: A blueprint for antibody design. Immunol Rev 2015; 268:201-21; PMID:26497522; http://dx.doi.org/10.1111/imr.12365
   PubMed Web of Science ®Google Scholar
• Traunecker A, Schneider J, Kiefer H, Karjalainen K. Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules. Nature 1989; 339:68-70; PMID:2541344; http://dx.doi.org/10.1038/339068a0
   PubMed Web of Science ®Google Scholar
• Byrn RA, Mordenti J, Lucas C, Smith D, Marsters SA, Johnson JS, Cossum P, Chamow SM, Wurm FM, Gregory T, et al. Biological properties of a CD4 immunoadhesin. Nature 1990; 344:667-70; PMID:1970124; http://dx.doi.org/10.1038/344667a0
   PubMed Web of Science ®Google Scholar
• Huber R, Deisenhofer J, Colman PM, Matsushima M, Palm W. Crystallographic structure studies of an IgG molecule and an Fc fragment. Nature 1976; 264:415-20; PMID:1004567; http://dx.doi.org/10.1038/264415a0
   PubMed Web of Science ®Google Scholar
• Prabakaran P, Vu BK, Gan J, Feng Y, Dimitrov DS, Ji X. Structure of an isolated unglycosylated antibody CH2 domain. Acta Crystallogr D Biol Crystallogr 2008; 64:1062-7; PMID:18931413; http://dx.doi.org/10.1107/S0907444908025274
   PubMed Web of Science ®Google Scholar
• Burton DR. Immunoglobulin G: Functional sites. Mol Immunol 1985; 22:161-206; PMID:3889592; http://dx.doi.org/10.1016/0161-5890(85)90151-8
   PubMed Web of Science ®Google Scholar
• Feinstein A, Richardson N, Taussig MI. Immunoglobulin flexibility in complement activation. Immunol Today 1986; 7:169-74; PMID:25290202; http://dx.doi.org/10.1016/0167-5699(86)90168-4
   PubMedGoogle Scholar
• Edelman GM, Cunningham BA, Gall WE, Gottlieb PD, Rutishauser U, Waxdal MJ. The covalent structure of an entire gammaG immunoglobulin molecule. Proc Natl Acad Sci U S A 1969; 63:78-85; PMID:5257969; http://dx.doi.org/10.1073/pnas.63.1.78
   PubMed Web of Science ®Google Scholar